Source: MSN


Some WWLTV viewers have heard that some treatments in other countries may be helping people with COVID-19. 

WWLTV’s medical reporter Meg Farris wanted to see if those treatments were available to hospital patients in the New Orleans area.

After President Trump’s announcement Thursday about promising treatments for COVID-19 we wanted to see what that means to us in Southeast Louisiana.

“Clinical trials are already underway for many new therapies and we’re working on scaling these to allow many more Americans to access different drugs that have shown really good promise,” President Donald Trump said.

LSU Health Science Center infection disease expert Dr. Meredith Clement said she’s used hydroxychloroquine to treat patients.

“We have been using hydroxychloroquine in patients with suspected and some with confirmed COVID-19 infection who have moderate and severe and even critical disease,” the doctor said.

Dr. Clement said local results have been variable, but they have been promising elsewhere.

“I do know that China is reporting that in 100 patients with it all patients did extremely well,” Clement said.

She and other local doctors have also been looking at very early, small, unpublished studies overseas combining hydroxychloroquine used for treating lupus and rheumatoid arthritis and the antibiotic azithromycin.

“They did show that the viral loads came down,” Clement said.

Dr. Clement said local hospitals were also using an antiviral drug that treats the Ebola virus here locally called remdesivir, but all of these medications — along with hydroxychloroquine used for decades to treat malaria — need more studies, she warned.

“These drugs are investigational. We are in the early days and we have only preliminary data to work with,” Clement said.

Read the original article here:

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »

The Chloroquine Wars Part XIV – How to Rig Research: Surgisphere Part I

It was in these very moments in late May when public health officials lost all credibility—a credibility that cannot be restored without major changes taking place. Despite most evidence pointing to a likelihood of HCQ efficacy, they made their call on the back of data supposedly tucked away in a database that nobody had verified, declared it definitive, then swiftly pushed for policy changes around the world.

Read More »